Clinical trial
Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study
NCT00230373 · University of Alberta, Other · Withdrawn
Key facts
| NCT number | NCT00230373 |
|---|---|
| Title | Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study |
| Official title | Evaluation of the Efficacy and Safety of Imiquimod 5% Cream in Plaque-type Morphea: A Pilot, Prospective Open-label Study |
| Lead sponsor | University of Alberta, Other |
| Collaborators | 3M Industry |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Morphea |
| Intervention type | Drug |
| Interventions | imiquimod 5% cream (Aldara) |
| Enrollment | 0 |
| Start date | Nov 1, 2005 |
| Completion | Jun 1, 2007 |
| First posted | Sep 30, 2005 |
| Last update posted | Apr 23, 2015 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: